The profound metabolic derangements observed in Klf15-deficient animals (i.e., obesity, dyslipidemia, nonalcoholic fatty liver disease, etc.)suggest that KLF15 critically interacts with other transcription factors in these metabolic networks. The gene discussed is KLF15; the disease is metabolic dysfunction-associated steatotic liver disease.